Deze vertaling wordt voorbereid. Voorlopig tonen we de oorspronkelijke Engelse versie.
Regelgeving en recht · 8-12-20171 min lezen
Prospective Grant of Exclusive Patent License: N-Acetyl Mannosamine as a Therapeutic Agent
Lokale automatische vertaling · Oorspronkelijke brontaal
Samenvatting
The National Human Genome Research Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this notice to Leadiant Biosciences, Inc, located in Gaithersburg, Maryland, USA.
Oorspronkelijke brontaal: Federal Register — All DocumentsOrigineel bericht openen →